Press releases

Orchard Therapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference

Orchard Therapeutics today announced that Mark Rothera, Orchard’s president and chief executive officer, will present at the RBC Capital Markets 2018 Global Healthcare Conference

Read more

Orchard Therapeutics Appoints Frank Thomas as Chief Financial Officer and Chief Business Officer

Orchard Therapeutics today announced the appointment of Frank Thomas to the newly created position of chief financial officer and chief business officer

Read more

Orchard Therapeutics Announces $110M Series B Financing to Advance Transformative Gene Therapy Pipeline

Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the completion of an oversubscribed $110 million (£85 million) Series B financing

Read more

Orchard Therapeutics and Généthon Announce Gene Therapy alliance in X-linked Chronic Granulomatous Disease

Orchard Therapeutics announces today a strategic alliance with Généthon, to develop gene therapy for X-linked chronic granulomatous disease (“X-CGD”)

Read more

Orchard Therapeutics Announces Expansion of Technical Operations in California

Orchard Therapeutics, today announced the opening of a second facility for technical operations in the San Francisco Bay Area

Read more